Pharmaceuticals company FDC announced Q1FY27 results Consolidated Financial Highlights: Total Income: The company reported a total income of Rs 71,535 lakh in Q1FY27, marking an increase of 12.71% from Rs 63,468 lakh in Q4FY26 and a growth of 4.60% from Rs 68,391 lakh in Q1FY26. Revenue from Operations: Revenue for Q1FY27 stood at Rs 66,769 lakh, reflecting a QoQ increase of 14.18% from Rs 58,479 lakh in Q4FY26 and a YoY increase of 2.97% from Rs 64,841 lakh in Q1FY26. Other Income: Other income for Q1FY27 was Rs 4,766 lakh, compared to Rs 4,989 lakh in Q4FY26 and Rs 3,550 lakh in Q1FY26. Net Profit: Net profit attributable to the owners of the parent for Q1FY27 was Rs 13,249 lakh, representing a growth of 28.13% from Rs 10,340 lakh in Q4FY26 and an increase of 9.18% from Rs 12,135 lakh in Q1FY26. For the full year FY26, the consolidated net profit was Rs 28,142 lakh. Profit Before Tax (PBT): PBT for the quarter stood at Rs 17,470 lakh, compared to Rs 14,035 lakh in Q4FY26 and Rs 15,978 lakh in Q1FY26. Earnings Per Share (EPS): Basic and diluted EPS for Q1FY27 was Rs 8.14, compared to Rs 6.35 in Q4FY26 and Rs 7.45 in Q1FY26. The annual EPS for FY26 was Rs 17.29. Standalone Financial Highlights: Total Income: Standalone total income in Q1FY27 was Rs 70,244 lakh, an increase of 14.87% from Rs 61,153 lakh in Q4FY26 and up 3.62% from Rs 67,787 lakh in Q1FY26. Revenue from Operations: Standalone revenue for Q1FY27 reached Rs 65,510 lakh, up 16.08% from Rs 56,435 lakh in Q4FY26 and up 1.99% from Rs 64,228 lakh in Q1FY26. For the full year FY26, standalone revenue was Rs 2,12,633 lakh. Net Profit: Net profit for Q1FY27 stood at Rs 13,202 lakh, reflecting a growth of 23.30% from Rs 10,707 lakh in Q4FY26 and an 8.04% increase from Rs 12,220 lakh in Q1FY26. The full year FY26 standalone net profit was Rs 28,592 lakh. Profit Before Tax (PBT): Standalone PBT for the quarter was Rs 17,427 lakh, compared to Rs 14,296 lakh in Q4FY26 and Rs 16,089 lakh in Q1FY26. Earnings Per Share (EPS): Standalone basic and diluted EPS for Q1FY27 was Rs 8.11, compared to Rs 6.58 in Q4FY26 and Rs 7.51 in Q1FY26. Business Highlights: Strategic Investment: The Board granted in-principle approval for an investment for a minimum 26% equity stake in Netra Green Energy Private Limited (a subsidiary of Sunsure Energy Private Limited). This investment is intended for power procurement under the Group Captive Solar Project for the company's API manufacturing plant at Roha, for an amount not exceeding Rs 45 lakh. Exceptional Items: The company noted that in the previous year (FY26), an incremental employee benefit obligation of Rs 2,079 lakh was recognized as an exceptional item due to a regulatory change in Labour Codes. No such exceptional item was reported for Q1FY27. Fair Value Adjustments: In Q4FY26, the company recognized a fair value loss of Rs 1,330 lakh under other expenses, while a net fair value gain of Rs 1,179 lakh was recognized under other income for the full year FY26 in accordance with Ind AS 109. Result PDF